# Microvascular Tissue, Inc – FDA Inspection, Apr 8, 2025

Source: https://www.keypedia.com/records/fda_inspections/microvascular-tissue-inc/3300ecef-3ed9-4dba-ad72-c49b9a900884
Source feed: FDA_Inspections

> FDA inspection 1266729 of Microvascular Tissue, Inc, April 08, 2025. 4 citations under 21 CFR part 211. Form 483 issued. 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1266729
- Company Name: Microvascular Tissue, Inc
- Inspection Date: 2025-04-08
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Center: Biologics
- Office Name: Los Angeles District Office
- Citation Count: 4

## Related Documents

- [FDA Inspection 1015454 - 2017-06-09](https://www.keypedia.com/records/fda_inspections/microvascular-tissue-inc/38a3140c-4ac6-4d0b-b0bf-4a35c56dbd9f)

## Related Officers

- [Investigator](https://www.keypedia.com/people/garrad-r-poole/7fc97953-367e-459b-905d-25efe6ec39d2)
- [Company Rep](https://www.keypedia.com/people/richard-t-riggie/d07a4551-08b4-44f7-b7d2-02ae3c5dc1e2)

Company: https://www.keypedia.com/companies/microvascular-tissue-inc/f7439e2a-45e9-4870-86dd-46af3dbd3cf4

Office: https://www.keypedia.com/offices/los-angeles-district-office/edcf1dfe-596a-43b8-8df4-07d9cd94763b
